Ocular toxicity associated with systemic drug therapy.
Systemic drug-induced ocular side effects are increasing because of the vast numbers of new drugs being introduced. Reports of drug-induced ocular toxicity must be well documented, and other causes of these side effects must be ruled out to help establish causality. We reviewed the most recent reports of the most commonly used and newest systemic drugs that have been implicated in ocular toxicity. Using toxicologic criteria needed to establish causality, data from reports of ocular toxicity associated with systemic cidofovir (Vistide), sildenafil (Viagra), vigabatrin (Sabril), tamoxifen (Nolvadex), hydroxychloroquine (Plaquenil)/chloroquine (Aralen), amiodarone (Cordarone), and lovastatin (Mevacor)/simvastatin (Zocor) were evaluated and summarized. The probability for causality was determined to be high for all these drugs except for vigabatrin and lovastatin/simvastatin. Methods for detecting, preventing, and treating ocular toxic reactions were then reviewed for each drug.
Moorthy
R S
RS
Indiana University School of Medicine, Indianapolis, USA.
Valluri
S
S
D000970:Antineoplastic Agents / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D004791:Enzyme Inhibitors / Q000009:adverse effects; D005123:Eye / Q000187:drug effects; D005128:Eye Diseases / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D014794:Visual Fields / Q000187:drug effects
D000970:Antineoplastic Agents; D018501:Antirheumatic Agents; D000998:Antiviral Agents; D004791:Enzyme Inhibitors